抗逆转录病毒治疗期间受孕女性的不良妊娠结局
研究纳入分娩后随机继续或停止抗逆转录病毒治疗(ART)的HIV感染非哺乳女性,比较后续妊娠结局。意向性分析中继续ART组 spontaneous abortion 或死胎风险高于停止ART组(RR 2.0,95%CI 1.1-3.5,P=.02),但按实际治疗分析未达统计学显著(RR 1.4,95%CI 0.8-2.4)。
要点
- 分娩后随机继续ART者后续妊娠发生自然流产或死胎的风险高于随机停止ART者(RR 2.0,95%CI 1.1-3.5,P=.02)。
- 按实际治疗分析该风险差异未达统计学显著(RR 1.4,95%CI 0.8-2.4)。
- 作者认为需要更多关于ART受孕女性妊娠结局的数据,尤其是新方案。
核心结论
- 随机分配继续ART的后续妊娠女性比随机分配停止ART者更可能发生自然流产或死胎,但按实际治疗分析未达统计学显著。
- 作者认为需要更多关于ART受孕女性妊娠结局的数据,尤其是新方案。
研究设计与样本
- HIV感染、非哺乳、ART前CD4计数≥400 cells/μL且在妊娠期间开始ART的女性,分娩后随机分配继续ART(CTART)或停止ART(DCART)。
- 随机分配至DCART的女性若后续妊娠或出现临床指征建议重启ART。
- 采用意向性治疗和按实际治疗两种方法,用Fisher精确检验比较随机分组间的后续妊娠结局。
主要发现
- 1652例女性中277例(17%)发生后续妊娠(CTART:144/827;DCART:133/825)。
- 266例(96%)有妊娠结局记录,中位年龄27岁(IQR 24-31岁),中位CD4+ T细胞计数638 cells/μL(IQR 492-833 cells/μL)。
- 自然流产与死胎合并,CTART组33/140(23.6%)vs DCART组15/126(11.9%)(RR 2.0,95%CI 1.1-3.5;P=.02)。
- 按实际治疗分析,RR降低且不再有统计学显著性(RR 1.4,95%CI 0.8-2.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 按实际治疗分析中风险比降低且不再有统计学显著性(RR 1.4,95%CI 0.8-2.4)。
- 作者认为需要更多关于ART受孕女性妊娠结局的数据,尤其是新方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adverse pregnancy outcomes for women who conceive on antiretroviral therapy (ART) may be increased, but data are conflicting. METHODS: Human immunodeficiency virus-infected, nonbreastfeeding women with pre-ART CD4 counts ≥400 cells/μL who started ART during pregnancy were randomized after delivery to continue ART (CTART) or discontinue ART (DCART). Women randomized to DCART were recommended to restart if a subsequent pregnancy occurred or for clinical indications. Using both intent-to-treat and as-treated approaches, we performed Fisher exact tests to compare subsequent pregnancy outcomes by randomized arm. RESULTS: Subsequent pregnancies occurred in 277 of 1652 (17%) women (CTART: 144/827; DCART: 133/825). A pregnancy outcome was recorded for 266 (96%) women with a median age of 27 years (interquartile range [IQR], 24-31 years) and median CD4+ T-cell count 638 cells/μL (IQR, 492-833 cells/μL). When spontaneous abortions and stillbirths were combined, there was a significant difference in events, with 33 of 140 (23.6%) in the CTART arm and 15 of 126 (11.9%) in the DCART arm (relative risk [RR], 2.0 [95% confidence interval {CI}, 1.1-3.5]; P = .02). In the as-treated analysis, the RR was reduced and no longer statistically significant (RR, 1.4 [95% CI, .8-2.4]). CONCLUSIONS: Women randomized to continue ART who subsequently conceived were more likely to have spontaneous abortion or stillbirth, compared with women randomized to stop ART; however, the findings did not remain significant in the as-treated analysis. More data are needed on pregnancy outcomes among women conceiving on ART, particularly with newer regimens.
引用
- Hoffman RM, Brummel SS, Britto P, et al. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy. Clin Infect Dis. 2019. PMID: 29868833. doi:10.1093/cid/ciy471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。